CDC Financial »

Zentalis Pharmaceuticals shares owned by CDC Financial

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by CDC Financial from 13F filings

Historical chart of CDC Financial investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by CDC Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by CDC Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $664k 284k 2.34

More positions owned by CDC Financial

Amplify Energy Corp (AMPY)
Century Aluminum Company (CENX)
Inhibrx Biosciences (INBX)
Atlas Energy Solutions Com New (AESI)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Vox Rty Corp Cda F (VOXR)
Apple Put Option (AAPL)
Health Catalyst (HCAT)
Immersion Corporation (IMMR)
Algoma Stl Group (ASTL)
Ring Energy (REI)
Afc Gamma Ord (AFCG)
Servicenow (NOW)
salesforce (CRM)
Inspired Entmt (INSE)

View all positions for CDC Financial

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
Two Sigma Investments
Renaissance Technologies
Vanguard Group
Acadian Asset Management
Vanguard Capital Management
Citadel Advisors
D. E. Shaw & Co
Opaleye Management
Decheng Capital
Millennium Management
BlackRock
Bank of America Corporation
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals